Login / Signup

Comparative Clinical Outcomes With Scale-up of Dolutegravir as First-Line Antiretroviral Therapy in Ukraine.

Konstantin DumchevTetiana KiriazovaSerhiy RiabokonAlyona ShostCanada ParrishAnna ShapovalMyroslava GermanovychJeremy PennerJason BesteNancy Puttkammer
Published in: Journal of acquired immune deficiency syndromes (1999) (2022)
DTG-based regimens were comparable with LPV and more effective than EFV in achieving viral suppression among ART-naive patients in a multisite cohort in Ukraine. Treatment retention was equally high in all 3 groups. This evidence from Ukraine supports the ART Optimization Initiative as a strategy to improve efficiency of the ART program without negatively affecting patient clinical outcomes.
Keyphrases